Advances and breakthroughs in prostate disease
Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.
Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Per-Anders Abrahamsson, a member of Perspectives' editorial and advisory board and Secretary General of the European Association of Urology, the leading professional organization overseas.
Hormone therapy for prostate cancer puts heart at risk
Physicians often prescribe androgen deprivation therapy, commonly called hormone therapy, to treat prostate cancer. The drugs, which have been given prior to surgery or in conjunction with radiation therapy, can shrink prostate tumors or slow their growth. But a recent study by researchers in Boston found a potential downside to hormone therapy: an increased risk of death from cardio-vascular disease, especially among patients who have prostate surgery.